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Background: Maternal mortality in referral hospitals in Mali and Senegal surpasses 1% of obstetrical admissions.
Poor quality obstetrical care contributes to high maternal mortality; however, poor care is often linked to
insufficient hospital resources. One promising method to improve obstetrical care is maternal death review. With a
cluster randomized trial, we assessed whether an intervention, based on maternal death review, could improve
obstetrical quality of care.
Methods: The trial began with a pre-intervention year (2007), followed by two years of intervention activities and a
post-intervention year. We measured obstetrical quality of care in the post-intervention year using a criterion-based
clinical audit (CBCA). We collected data from 32 of the 46 trial hospitals (16 in each trial arm) and included 658
patients admitted to the maternity unit with a trial of labour. The CBCA questionnaire measured 5 dimensions of
care- patient history, clinical examination, laboratory examination, delivery care and postpartum monitoring. We
used adjusted mixed models to evaluate differences in CBCA scores by trial arms and examined how levels of
hospital human and material resources affect quality of care differences associated with the intervention.
Results: For all women, the mean percentage of care criteria met was 66.3 (SD 13.5). There were significantly
greater mean CBCA scores in women treated at intervention hospitals (68.2) compared to control hospitals (64.5).
After adjustment, women treated at intervention sites had 5 points’ greater scores than those at control sites. This
difference was mostly attributable to greater clinical examination and post-partum monitoring scores. The
association between the intervention and quality of care was the same, irrespective of the level of resources
available to a hospital; however, as resources increased, so did quality of care scores in both arms of the trial.
Conclusions: Patients treated at hospitals with maternal death review had greater CBCA scores suggesting that the
intervention improves quality of care. Results indicate that the intervention mostly improves clinical examination at
admission and post-partum monitoring. They also indicate that quality of care scores can be maximized by
increasing the availability of human and material resources to hospitals in the region.
Trial registration: The QUARITE trial is registered on the Current Controlled Trials website under ISRCTN46950658
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Each day, 800 women worldwide die during pregnancy or
of childbirth-related causes. Most maternal deaths occur in
sub-Saharan Africa [1]. Globally, it is recognized that
significant inroads in maternal mortality cannot be made
without dramatically increasing access to emergency obstet-
rical care (EmOC) [2]. Hospitals capable of basic EmOC
should provide parental antibiotics, anticonvulsants, and
oxytocics, as well as be able to manually remove the pla-
centa and retained uterine products, and perform assisted
deliveries. Comprehensive EmOC sites also perform caesar-
ean sections and blood transfusions [3]. Yet, in many
places, the numbers of maternal deaths occurring in health
facilities providing EmOC are unacceptably high. In Mali
and Senegal, over one percent of women die giving birth in
referral hospitals across the region, in places where com-
prehensive EmOC is available [4]. Such high case fatality
suggests that poor medical practice may contribute to ma-
ternal mortality, along with other factors such as long travel
times and late recognition of obstetrical complications.
While elevated facility maternal mortality indirectly
suggests deficiencies in quality of care, little work in the
region has directly measured the problem. Anthropologists
working in five West African capital cities have docu-
mented shocking departures from quality obstetrical care.
These ranged from gross neglect to physical violence
against patients [5]. Additionally, limited quantitative evi-
dence has indicated that over 70% of maternal deaths in
the region could be avoided with better quality care [6].
While sobering, this work does not quantify the amplitude
of the quality problem nor give health professionals con-
crete suggestions on how to improve obstetrical practice.
Recently, there has been substantial interest in employing
maternal death review (MDR) to improve obstetrical quality
of care and reduce maternal mortality [7-10]. MDR are
audits of maternal deaths in which all healthcare staff
involved in the management of a particular patient discuss
the circumstances of the death and how care could have
been improved. During the audit, recommendations to im-
prove future patient care are made [7]. In Senegal, a pilot
study using MDR showed a 50% reduction in maternal
mortality [11]. MDR are believed effective at improving ob-
stetrical care because they draw hospital staff attention to
the problem of maternal mortality, highlight quality gaps,
and emphasize finding solutions that are realistic in a given
setting. Overall, they are believed to increase provider
accountability.
In September, 2007, the QUARITE cluster randomized
trial was initiated to assess the effect of a multifaceted
intervention, the ALARM International Program, on re-
ducing facility maternal mortality [4]. The hallmark of
the intervention is MDR. Other aspects of the interven-
tion include workshops on obstetrical best practices and
periodic visits to ALARM sites by international experts.It is believed that the workshops and international visits
facilitate MDR by providing health care professionals
with the knowledge and confidence to make quality
improvement suggestions during the reviews. In all, the
ALARM program targets heath professionals in maternity
units and is believed to reduce maternal mortality by im-
proving quality of care, through better obstetrical practice.
For the trial, we randomly allocated the ALARM interven-
tion to referral hospitals in the region. To avoid contamin-
ation between health professionals, and because the
intervention targets teams of professionals, a cluster de-
sign was deemed more appropriate than an individual
randomized controlled trial.
Methods
The QUARITE trial began in September 2007 and was
completed in December 2011. It consisted of a one-year
pre-intervention period, a two-year intervention period,
and a final year post-intervention period. A detailed de-
scription of the trial design and objectives has been
described elsewhere [4]. The trial received ethics commit-
tee approval from Sainte Justine Hospital in Montreal (ref.
2425), the Ministry of Health and Preventive Medicine in
Senegal (ref. 0869), and the National Ethics Committee
for Health and Life Sciences in Mali (ref. 034/MS-
SG-CNESS). Informed consent was obtained from each
hospital included in the trial.
Setting
The QUARITE trial took place in referral hospitals in Mali
in Senegal. Referral hospitals are evacuation sites for
complicated deliveries and in theory, should have sufficient
infrastructure to provide comprehensive EmOC including
caesarean section and blood transfusion [3]. In both coun-
tries, there are sufficient numbers of comprehensive
EmOC facilities for the population, though rural areas are
underserved [12]. In Mali, approximately 45% of women
give birth in a basic or comprehensive health facility and of
those whose births were assisted by a health professional,
2% received a caesarean section [13]. In Senegal, the re-
spective proportions are 62% and 3% [14].
Participants
As this is a cluster design, eligibility criteria apply to
both the hospital and patient levels of analysis. To be
eligible for the QUARITE trial, the referral hospital
needed to have comprehensive EmOC capacity (i.e. a
functioning surgical theatre and blood transfusion cap-
acity) and at least 800 births per year. We focused on
high volume hospitals in order to have enough maternal
deaths (main trial outcome) and because the health sys-
tem is organized in a pyramidal fashion. That is, lower
order health centres refer cases of complication up to
higher level, larger facilities that, in theory, should be able
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QUARITE’s eligibility criteria have been described in detail
elsewhere, and a total of 46 of the 49 eligible referral
hospitals were included in the trial [4]. For the present
study and analyses, all women admitted to hospital with a
trial of labour and a foetus of at least 500gms were eligible
for this sub-study. Women admitted for elective caesarean
section were not included, because they did not have a
trial of labour. Elective caesarean section accounted for
two percent of all birth in the trial [15].
We sampled the charts of two populations of women.
Providers were not aware of which charts would be
sampled until the day of data collection which was after all
care had been provided to the obstetrical patient. The first
sample, called the consecutive sample, included the last
20–25 births having occurred at a hospital as of September
30, 2010. It was a random snap shot of the population of
women attending a given hospital on an arbitrary date and
included some of the women in the second sample. The
second sample, called the complicated sample, included
only women with severe pre-eclampsia and/or eclampsia
and post-partum haemorrhage (defined below). We only
looked at pre-eclampsia and haemorrhage, because these
were the two most frequent and lethal complications of
women treated in trial hospitals, according to data collected
during the baseline year of QUARITE. Women in the
complicated sample were selected within a three-month
sampling frame: July-September, 2010 in Senegal and
September-November, 2010 in Mali. We aimed for 10–15
complications per hospital, starting in September and
working backwards in Senegal (and forwards in Mali) until
the desired sample size was achieved or the sampling frame
was exhausted. The dates of the sampling frames differ
slightly because of when data was collected and the
availability of records for audit (Mali was sampled after
Senegal).
To locate cases of severe (pre-) eclampsia/ eclampsia and
post-partum haemorrhage, we used three data sources: the
delivery register, the patient medical chart, and the
QUARITE trial data sheet (records basic information on all
women giving birth in trial hospitals, including diagnoses
of obstetrical complication). Prior to QUARITE trial com-
mencement, staff at both intervention and control sites
received training on the diagnosis of obstetrical com-
plications according to international guidelines. This was
done to ensure consistency in the definitions of complica-
tion used across sites.
For this sub-study, we assessed the care of patients
with severe pre-eclampsia/ eclampsia and post-partum
haemorrhage. To locate cases of severe pre-eclampsia
or eclampsia, we searched the three forms of medical
records described above. We looked for a diagnosis of
pre-eclampsia, toxaemia, or eclampsia, as recorded by a
healthcare professional (usually a midwife or doctor).Since many pre-eclampsia patients had mild to mo-
derate pre-eclampsia, we also looked for the following
indications of severe pre-eclampsia: mention of severity,
convulsions, albumin laboratory scores of +++, and
vomiting. For post-partum haemorrhage, in addition to
an express diagnosis of the complication, we looked in
depth at patients with antenatal haemorrhage (placenta
praevia, abruptio-placentae) continuing into the post-
partum period. We looked for indicators of postpartum
haemorrhage such as: an important postpartum drop in
blood pressure and/or post-partum blood pressure below
90/50 [16]; a postpartum drop in haemoglobin levels [17],
retained placental fragments or incomplete expulsion of
the placenta, mention of uterine atony, intravenous post-
partum administration of oxytocin or post-partum blood
transfusion. We did not include blood loss because this
was not recorded in the patient medical records and be-
cause physiological change may be more appropriate in
this context, as there is a high prevalence of anaemia [18].
The case notes for each obstetrical complication were veri-
fied by an obstetrician gynaecologist (AD) in order to re-
duce the inclusion of false positives.
Intervention
The ALARM International Program was developed by the
Society of Obstetricians and Gynaecologists of Canada. It
combines clinically-oriented and evidence-based outreach
visits with facility-based MDR. Specifically, the interven-
tion included the following activities: 1) A six-day work-
shop to train and certify opinion leaders (one physician
and midwife from each intervention site) in EmOC best
practices, audit techniques, and sexual and reproductive
rights; 2) the creation of a multidisciplinary audit commit-
tee (physicians, midwives, nurses, and administrators) at
each site; 3) commencement of a once-monthly audit
cycle according to WHO guidelines [7]; 4) the training of
qualified staff in obstetrical best practices with 4–8
training sessions during the intervention period organized
by local opinion leaders and external facilitators; 5) Educa-
tional outreach every three months by external facilitators
including a national opinion leader and an ALARM inter-
national coordinator to support local opinion leaders in
their activities and; 6) Recertification of local opinion
leaders a year after initial certification with an accelerated
training workshop. A more detailed description of the
intervention has been published elsewhere [4]. The con-
trol group did not receive any intervention by the research
team after the baseline year. In other words, normal
practice continued at the control sites including infre-
quent training courses (mostly related to HIV care) for
obstetricians and midwives and some oversight by
regional and national governments regarding the numbers
of maternal deaths and prevention of mother to child
transmission of HIV. It should be noted that these same
Pirkle et al. BMC Pregnancy and Childbirth 2013, 13:24 Page 4 of 13
http://www.biomedcentral.com/1471-2393/13/24activities were also carried out at ALARM sites. The
ALARM program was implemented in addition to existing
activities in the region.Objectives
The primary objective of the trial was to reduce facility
maternal mortality (results forthcoming). Secondary
objectives of the trial included: 1) reducing stillbirth and
neonatal mortality; 2) reducing severe maternal morbid-
ity; 3) improving quality of care and 4) increasing health
professional job satisfaction [4]. In this paper, we address
the secondary objective of improving quality of care, as
it is the mechanism by which the ALARM intervention
is believed to reduce maternal mortality. In other words,
we did not expect significant reductions in facility ma-
ternal mortality without first seeing improvements in
obstetrical care.
Here, we evaluate the effect of ALARM on obstetrical
quality of care during labour, delivery and the immediate
post-partum period. It is during this period that most ma-
ternal deaths occur [19]. We assess whether quality of care
at the patient level differs according to trial arms (ALARM
versus control sites) and whether certain aspects of the
care process have been differentially affected by the
intervention.Outcomes
The primary outcome of this study was patient intra-
partum quality of care, as measured with chart abstrac-
tion (see below). Secondary outcomes for this study
were: scores for different dimensions of quality, quality
scores for severe pre-eclampsia and eclampsia, and qual-
ity scores for postpartum haemorrhage.
Quality of care was assessed with a form of chart ab-
straction known as criterion-based clinical audit (CBCA)
[7]. When using CBCA, standardized criteria for evaluat-
ing good quality of care are predetermined, usually with
medical literature and expert opinion, and then compared
against data extracted from medical records to evaluate
whether or not a minimal standard of care has been met
[5,14]. CBCA is formatted to look like a checklist of pre-
specified standards of good care. For example, the auditor
may “check-off” if a patient’s blood pressure, cardiac fre-
quency, and temperature were taken. For each affirmative
response related to an expected standard of care, a point
is given. The points are tallied up and divided by the total
possible in order to assign a quality of care score to each
patient.
The CBCA that we used has been described exten-
sively elsewhere [20] and is both a valid and reliable tool
for measuring obstetrical quality of care. Prior to con-
ducting the audit, we piloted the questionnaire on 185medical charts to assess inter-rater reliability and to
maximize content validity. Additional analyses of the
CBCA instrument showed that low scores (less than
70% criterion attainment) predict perinatal mortality;
this strongly indicates construct validity [20]. Addition-
ally, because of concerns that missing patient obstetrical
charts might lead to selection bias [21], we systematically
recorded the numbers of missing records and patient
characteristics (patient age; vaginal birth versus caesarean
section) based on data collected from the delivery register.
We assessed if there was an association between patient
characteristics and missing obstetrical records and found
no association. This suggests that records were missing at
random, as patient characteristics for retrieved and non-
retrieved records were similar [20].
The CBCA contains 26 unweighted criteria that measure
5 dimensions of care: patient history, clinical examination,
laboratory examinations, labour management (partograph),
delivery care and postpartum monitoring. These sections
apply to all women sampled. A quality of care score was
attributed to each woman based on the number criteria
met. For example, if 20 criteria were attained during the
audit of a given medical record, then the score for that rec-
ord would be 20/26 or 76.9%. In accordance with previous
studies [7], we also defined a binary outcome to assess
quality of care as follows: good care defined as greater than
70% criterion attainment versus moderate to poor care
defined as 70% or less attainment [20]. Finally, two sections
of the questionnaire applied only to women with severe
pre-eclampsia/eclampsia and postpartum haemorrhage.
These were scored separately (denominator of 7 for each).
Table 1 shows the criteria included for each section.
Sample size
We used Hayes and Moulton’s (2009) formula for cluster
randomized trials with a quantitative endpoint [22]. Our
endpoint was mean patient CBCA score. Previous work
in low- and middle- income countries has shown post-
audit improvements in quality of care scores of 15-35%
[21]. We conservatively estimated that mean patient CBCA
scores at ALARM hospitals would be 15% greater than at
control sites. We assumed that standard deviations around
the CBCA score would be the same in both groups and
estimated them to be 0.15. We expected a high degree of
within cluster correlation in CBCA scores, because facility
institutional culture would likely lead similar obstetrical
care and recording practices. We thus used a highly conser-
vative intra-class correlation coefficient of 0.50. Given that
we planned to sample 20 medical charts per hospital for
the consecutive sample, 9 hospitals per trial arm would be
necessary to detect a significant difference between inter-
vention and control groups, with 80% power and an alpha
of 0.05. For the subsamples of post-partum haemorrhage
and severe pre-eclampsia and eclampsia, which used only
Table 1 Criteria included in the CBCA to measure obstetrical quality of care
Dimension Criteria
History taking • Condition of the mother at arrival









• Foetal heart beat
• Membranes/amniotic fluid
• Cervical dilation




Monitoring during birth • Name of person who assisted the birth
• Qualification of the birth attendant
• Time of placental expulsion
• Oxytocin given
• Time of birth given
Postpartum monitoring • Follow-up examination
• Exit examination
• Date of exit
• Condition of the infant at birth
Severe pre-eclampsia and eclampsia (specific to women with this diagnosis
only)
• Anticonvulsant administered
• Blood pressure recorded every four hours after birth
• Urinary output measured at least once in 24 hours
• Test of bleeding time
• Test of coagulation rate
• Platelet count
• Albumin test
Post-partum haemorrhage (specific to women with this diagnosis only) • Pulse and blood pressure every 15 minutes for 2 hours after
diagnosis
• Injection of oxytocin or egometrine
• Intravenous oxytocin perfusion
• Placenta expulsed
• Test of bleeding time
• Test of coagulation rate
• Platelet count
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trial arm to detect a significant difference between arms.
Randomization
Centres were included on the basis of formal, informed
consent on the part of the hospital director and the
person in charge of maternity services. After a one-year
pre-intervention data collection phase, each hospital was
randomly assigned (August 2008) to either an interven-
tion group, in which ALARM was implemented, or a
control group.
The participating hospitals were stratified into six strata
corresponding to the combination of two countries (Mali
and Senegal) and three hospital types: hospitals in the cap-
ital, regional hospitals, and district hospitals outside the
capital. We attempted to ensure optimal balance between
the hospitals assigned to the intervention and the control
groups in terms of their number and size (number of de-
liveries per year). Therefore, within each stratum, we first
ranked the hospitals with respect to size, and then used
blocked randomization, with each block of size two,
containing two hospitals with adjacent ranks, i.e., of simi-
lar size. All participating hospitals were randomized sim-
ultaneously, after their list was provided, which eliminated
any risk of allocation bias.
Blinding
Patients attending the study facilities were blinded to
group assignment. For obvious reasons, those admi-
nistering the intervention and health professionals im-
plementing the intervention were not blinded.
Statistical methods
All statistical analyses were conducted in SPSS 17.0. We
used t-tests to assess if there were statistically significant
differences in CBCA scores according to arms of the
QUARITE trial (ALARM versus control). We used mixed
models, which take into account clustering by hospital, to
examine predictors of CBCA score. Because of the limited
number of clusters in most CRTs, it is not unusual to find
imbalances in covariates between trial arms [22]. Thus, at
the cluster level, we adjusted for country, material and
human resources available for obstetric care (see below),
and capital versus regional location. At the patient level,
we assessed for confounding by age, parity and the
number of prenatal consultations. We entered each pa-
tient variable one at a time to evaluate changes in the co-
efficient for ALARM. Changes of greater than 10% were
considered potential confounding.
For each site, we collected information on material and
human resources allowing us to score the structural cap-
acity of each centre. This score, called the Complexity
Index Score, was derived from an instrument used in the
WHO Global Survey on Maternal and Perinatal Health[23]. It is comprised of eight categories describing: 1) basic
services (e.g. water, electricity, etc.), 2) screening tests
(proteinuria, urine culture, etc.), 3) basic emergency ob-
stetrical resources (antibiotics, hysterectomy, transfusion,
etc.), 4) intrapartum care (partograph use, skills in forceps,
etc.), 5) general medical services (e.g. medical laboratory,
sterilization equipment, etc.), 6) anaesthesiology resources
(anaesthesiologist present 24h, equipment for general an-
aesthesiology, etc.) 7) human resources (nurse, midwife,
etc.) and, 8) academic resources and clinical protocols
(medical library, internet, etc.). We used an Africa-specific
grading scheme for the Index proposed by Shah [24].
A list of services under each of the categories des-
cribed above is classified as essential, comprehensive, or
advanced. Each service classified as essential receives one
point, each comprehensive service receives two points,
and each advanced service gets 3 points. Points for the
Complexity Index were summed up for each hospital.
Scores can vary from 0 to 100. For the Complexity index
score, we centred the values around the mean to make the
results more easily interpretable.
Because the Malian and Senegalese health systems are
organized differently, we also assessed for effect modifi-
cation by country. Similarly, we assessed for effect modi-
fication by Complexity Index Score, hypothesizing that




Figure 1 shows the numbers of clusters followed through
each stage of the study. Because of logistical and financial
constraints, for this study on quality of care, we only
analyzed 32 of the 46 study hospitals.
Numbers analysed
This is an intention to treat analysis. In each trial arm,
there were 16 clusters (hospitals). We analyzed data from
two samples: the consecutive (N = 658) and complicated
samples (N = 209). Figure 1 shows the numbers of clusters
and charts analysed in each trial arm.
Baseline data
Table 2 shows that the hospital and patient characteristics
were very similar at the ALARM and control sites. There
were, however, more district and regional sites among
those not sampled; parity in patients from these hospitals
was higher.
Observations in the consecutive sample were well-
distributed according to the intervention (48.5% at
ALARM sites and 51.5% at control sites) and by location
(33.4% in the capital versus 66.6% at district or regional
hospitals). In the complicated sample, there were slightly
more observations in the control arm than the ALARM
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Index score around the mean, 45.4% of observations in
the consecutive sample were below the mean while
54.6% were above it. In the complicated sample, 39.2%
of observations were below the mean Complexity index
score while 60.8% were above it. This is expected, as
higher-level hospitals attract more cases of obstetrical
complication.
Outcomes and estimation
For the consecutive sample (N = 658 patients), the mean
CBCA score was 66.30 (SD 13.46) and the mean
Complexity index score was 68.27 (SD 10.21). For the
complicated sample (N = 209 patients), the respective
means were 69.11 (SD 12.42) and 68.54 (SD 9.36). For 27
(4.1%) women we could not calculate a CBCA score due
to missing information in the consecutive sample. A
slightly higher proportion (6.7%) could not be calculated
for the complicated sample.
In both samples, unadjusted analyses indicate that there
were significantly greater mean CBCA scores in women
treated at ALARM hospitals compared to women treated
at control hospitals. This difference was mostly attribut-
able to greater patient scores for clinical examination at
admission and post-partum monitoring scores (Table 3).
We also looked at differences in the proportions of
women receiving good quality care (greater than 70%
criteria attainment) versus moderate to poor care (70%
or fewer criteria attained). In the consecutive sample,
significantly more women at ALARM sites received
good quality care compared to women at control sites
(44.1% versus 29.7%, p = 0.000). In the complicatedFigure 1 Flow diagram of clusters and medical charts included in thesample, a similar difference between ALARM and con-
trol sites was observed (50.0% at ALARM sites versus
37.4% at control sites, p = 0.08).
For the subsections of the CBCA questionnaire pertaining
to the direct complications of severe pre-eclampsia/
eclampsia and post-partum haemorrhage, there were no sig-
nificant differences in total scores between arms of the
QUARITE trial. Overall, criteria attainment for these
sections of the questionnaire was very low (Tables 4 and 5).
However, there were notable differences between trial
arms for specific criteria within each section. While not
statistically significant, for most criteria ALARM sites
tended to have greater individual criterion attainment with
the exception of criteria related to laboratory tests.
Predictors of CBCA score
We used the larger consecutive sample to assess pre-
dictors of CBCA score. Table 6 presents results from the
mixed models analysis. After adjusting for all relevant
covariates, ALARM was significantly associated with
CBCA score. Women treated at ALARM sites have, on
average, 5 percentage points’ greater CBCA scores than
those treated at control sites. Country predicted CBCA
score better than any other variable; women treated at
sites in Senegal have lower average CBCA scores than
women treated in Mali. Complexity score was associated
with better CBCA score in Mali, but not in Senegal. The
number of patient prenatal visits was not significantly
associated with CBCA score, but it was a potential
confounder and thus, we preferred to retain it in the
final model.study.
Table 2 Baseline characteristics of ALARM, control, and excluded sites
ALARM sites* Control sites* Not sampled¥
Mali 6 7 9
Senegal 10 9 5
No. Capital sites 5 6 1
No. Regional/District 11 10 13
Mean patient age (SD) 25.7 (6.8) 25.8 (6.6) 25.2 (6.7)
Mean patient parity (SD) 2.3 (2.3) 2.1 (2.3) 3.3 (2.4)
Mean no. prenatal visits (SD) 3.1 (1.7) 3.0 (1.6) 2.8 (1.8)
*Calculated from the consecutive sample.
¥Data obtained from QUARITE trial database for same three-month study period (N = 5764 for age, 5776 for parity, and 5774 for prenatal visits).
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CBCA scores for three different scenarios of Complexity
index score (10 points below the average score, the aver-
age score, and 10 points above the average score) for a
woman with the recommended number of prenatal visits
(4 or more).
In Mali, a ten-point increase above the average Com-
plexity index score has a slightly more important effect
on CBCA score than the ALARM intervention (6% im-
provement for Complexity index score versus 5% for
ALARM). In Senegal, however, a 10-point increase above
the average Complexity index score has a less important
effect on CBCA score than ALARM (1% improvement
for Complexity index score versus 5% for ALARM).
Discussion
This was a sub-study of data from the QUARITE cluster
randomized controlled trial. In this study, we attempted
to parse out potential mechanisms of effect for the
ALARM intervention. By doing so, we hoped to better
understand how the intervention worked and what
aspects of the intervention can be modified for future
quality improvement efforts. Analyses from this study
indicate that women treated at hospitals with the
ALARM intervention have modestly greater mean
CBCA scores. This suggests that the intervention is hav-
ing the desired effect; it is associated with better obstet-
rical quality of care. Further, 15% more women are
receiving good care (70% or greater criterion attain-Table 3 Unadjusted patient CBCA sores according to sample
Consecutive sample
N ALARM (% ) Co
Initial interview 639 82.3% 81
First clinical exam 657 86.4%* 80
Laboratory exams 654 33.3% 31
Delivery and birth 657 63.3% 62
Postpartum monitoring 655 56.2%* 46
Total 631 68.2%* 64
*p-value for t-test ≤ 0.05.ment) at ALARM hospitals when compared to control
hospitals.
Results indicate that the intervention mostly improves
clinical examination at admission and postpartum
monitoring. There is also a trend suggesting that
ALARM may be associated with increased use of mag-
nesium sulphate in women with severe pre-eclampsia/
eclampsia. Finally, there was significantly greater admin-
istration of oxytocin for women with post-partum haem-
orrhage at ALARM sites and a greater proportion of
women with post-partum haemorrhage at these sites
were recorded as having had the placenta removed
manually.
This study looks at the potential mechanisms of a
complex quality improvement intervention and points to
areas for future focus, specifically laboratory tests and
birth and delivery care. It goes beyond simply assessing
efficacy. By attempting to better elucidate what worked
and why, we “look more closely inside the ‘black box’ of
an intervention” ([25] p792), in order to better guide the
development of future quality improvement programs. It
takes a comprehensive look at quality of care evaluating
both structure- (Complexity Index score) and process-
level (CBCA score) components of care [26]. Quality of
care is frequently proxied by the availability of hospital
infrastructure and human resources based on the as-
sumption that medical practice will improve as these
resources increase [26]. We take a more nuanced view,
acknowledging that context may determine the relativeand ALARM intervention
Complicated sample
ntrol (%) N ALARM (%) Control (%)
.1% 203 81.8% 81.4%
.5% 209 84.6% 80.7%
.7% 204 40.2% 33.6%
.8% 207 68.1% 71.0%
.1% 208 63.0%* 49.8%
.5% 195 71.5%* 67.1%
Table 4 Criterion attainment for women with severe pre-eclampsia/eclampsia according to the ALARM International
Program
Criterion ALARM (n,%) Control (n,%) p-value
N = 68 N = 70
Anticonvulsant administered
Magnesium sulphate 26, 38.2% 20, 28.6%
Valium 7, 10.3% 7, 10.0%
None 35, 51.5% 43, 61.4% 0.455
Blood pressure recorded every four hours after birth
Yes 15, 22.1% 13, 18.6%
No 53, 77.9% 57, 81.4% 0.675
Urinary output measured at least once in 24 hours
Yes 22, 32.4% 22, 31.4%
No 46, 67.6% 48, 68.6% 1.000
Test of bleeding time
Yes 5, 7.4% 10, 14.3%
No 63, 92.6% 60, 85.7% 0.275
Test of coagulation rate
Yes 5, 7.4% 9, 12.9%
No 63, 92.6% 61, 87.1% 0.346
Platelet count
Yes 22, 32.4% 17, 24.3%
No 46, 67.6% 53, 75.7% 0.346
Albumin test
Yes 18, 26.5% 18, 26.1%
No 50, 73.5% 51, 73.9% 1.00
Total severe (pre-) eclampsia score 25.2% 23.2% 0.621
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http://www.biomedcentral.com/1471-2393/13/24importance of each component of quality of care. In
Senegal, for example, we saw that the ALARM interven-
tion, which focused on medical practice, had more influ-
ence on intrapartum quality of care than resource
availability. However, in Mali, where resources are lower
than in Senegal, both the ALARM intervention and re-
source availability were important predictors of quality.
There are several strengths to this study. To our
knowledge, this is the first validated CBCA to be used in
a resource-limited setting to measure obstetrical care
[21]. This was a very large audit of over 800 women
(both samples) across 32 hospitals. Because of this, we
were able to document the extensive variability in care
that women received at referral facilities across the re-
gion. The breadth of the study, and the use of a validated
CBCA instrument to quantitatively measure obstetrical
care, gives us confidence that ALARM is, in fact, a prom-
ising quality improvement tool that can be applied in a
wide variety of settings. In a trial of this size, one wouldexpect effect dilution due to factors such as incomplete
implementation of the program [27]. Given the inevitabil-
ity of effect dilution, significant results showing quality of
care improvements are encouraging and may suggest that
the ALARM intervention can be generalized in low-
income settings.
We sub-sampled women with direct complications that
are both prevalent and have high case-fatality rates in
West African hospital settings [28]. We were surprised to
find that the ALARM intervention had a limited effect on
the care of women with severe pre-eclampsia/ eclampsia.
The care of this complication may be strongly influenced
by resource availability. For example, in Mali, most district
hospitals did not have sufficient laboratory resources to
detect biological signs of severe pre-eclampsia, such as
tests of proteinuria. These signs are frequently used as
indicators for the use magnesium sulphate. However, even
at sites with sufficient resources, complications appeared to
go unrecognized. For both of the complications sampled,
Table 5 Criterion attainment for women with post-partum haemorrhage according to the ALARM International
Program
Criterion ALARM (n,%) Control (n,%) p-value
N = 58 N = 64
Pulse and blood pressure every 15 minutes for 2 hours after diagnosis
Yes 8, 13.8% 6, 9.4%
No 50, 86.2% 58, 90.6% 0.57
Injection of oxytocin or egometrine
Yes 18, 31.0% 9, 14.1%
No 40, 69.0% 55, 85.9% 0.03
Intravenous oxytocin perfusion
Yes 27, 46.6% 23, 35.9%
No 31, 53.4% 41, 64.1% 0.27
How the placenta was expulsed
Spontaneously 10, 17.5% 13, 21.3%
Manually 43, 75.4% 35, 57.4%
Not recorded 4, 7.0% 13, 21.3% 0.05
Test of bleeding time
Yes 7, 12.3% 19, 29.7%
No 50, 87.7% 45, 70.3% 0.04
Test of coagulation rate
Yes 7, 12.3% 18, 28.1%
No 50, 87.7% 46, 71.9% 0.06
Platelet count
Yes 28, 49.1% 35, 54.7%
No 29, 50.9% 29, 45.3% 0.48
Total post-partum haemorrhage score 36.7% 34.9% 0.586
Table 6 Mixed-models analysis of predictors of CBCA score (N = 618)
Variable Estimate 95% Confidence interval P-value
Intercept 0.756 0.706 – 0.806 0.000
ALARM
Intervention 0.052 0.003 – 0.102
Control - - 0.040
Country
Senegal −0.184 −0.240 – -0.128
Mali - - 0.000
Centred complexity score 0.006 0.002 – 0.011 0.005
Prenatal visits
3 or less −0.012 −0.028 – 0.003
4 or more - - 0.108
Country-Complexity interaction
Senegal*Complexity −0.005 −0.011 – 0.000 0.055
Mali*Complexity - -
















Figure 2 Relationship between CBCA and Complexity Index
score according to ALARM in Mali.
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http://www.biomedcentral.com/1471-2393/13/24we were not able to rely exclusively on provider diagnoses.
Sometimes, complications were simply not detected or
euphemisms were employed (e.g. “endometriosis” following
caesarean section instead of postpartum haemorrhage). As
a result, we used multiple signs of complication (see
participants section of methods) to detect cases severe pre-
eclampsia/eclampsia and postpartum haemorrhage. By
doing so, we increased the sensitivity of our case definition
but may have reduced specificity (e.g. more false positives).
Nonetheless, it is obvious that medical care for a complica-
tion cannot be improved if that complication is not
acknowledged/ detected. Thus, future efforts need to im-
prove the recognition of obstetrical complications.
There are limitations to this study. By not sampling all
46 hospitals in the QUARITE trial, we may have broke-
down the initial randomization. For this reason, we
considered potential confounders at both the hospital
and patient levels. Given that hospitals in our sample
were well-balanced by trial arm and by level (capital, re-
gional, district) and that patient variables, such as age
and parity, were not confounders, suggests that we did
not introduce bias with the smaller sample. However,
the proportion of district-level hospitals was greater in















Figure 3 Relationship between CBCA and Complexity Index
score according to ALARM in Senegal.study may be less generalizable to lower-level referral
hospitals.
An additional limitation is related to the sample size
for both of the direct obstetrical complications sampled.
It is possible that we would have observed a significant
result for the administration of magnesium sulphate at
ALARM sites had we had a larger sample of clusters in
both trial arms. There was very large variability at both
the patient and hospital levels for the treatment of these
complications. This reduced precision around the ef-
fect estimate and thus, our ability to detect a significant
result. A larger sample would have allowed us to better
interpret the laboratory results, as very few women
received recommended laboratory tests for both com-
plications. It should be noted that no patients in Mali
were recorded as having tests of bleeding time or coagu-
lation rate. Estimators for these criteria are thus very
unstable.
Finally, the greatest weakness of CBCA is that it is
dependent on what is recorded. In applying this tool,
one assumes that what is recorded in the medical chart
has actually been done and what has not been recorded,
has not been done. This assumption may be flawed. For
example, in Senegal, the name and qualification of the
person who assisted the birth was recorded about a
quarter of the time and in 80% of these cases, informa-
tion was only recorded when the woman was seen by a
medical doctor. Incomplete recording practices in Sene-
gal may partially explain why CBCA scores were signifi-
cantly lower there, compared to Mali. Nonetheless,
charting is itself an indicator of quality of care. Good
charting is necessary because the medical team following
a woman may change over the course of a day and im-
portant decisions, such as when to conduct a caesarean
section, are best made with the aid of tools such as the
partograph [29].Conclusion
The ALARM intervention appears to improve certain
aspects of the care process (clinical examination and
post-partum monitoring), but other aspects (laboratory
tests, delivery care) need further programmatic targeting.
There is evidence suggesting that the program improves
the care of women with post-partum haemorrhage, but
that it is less effective for cases of severe pre-eclampsia/
eclampsia. Resource limitations, particularly in Mali, may
be slightly more influential in determining the care of
these patients (especially those with direct complications)
than interventions targeting medical practice. Overall,
these analyses demonstrate that future efforts in the re-
gion need to continue to target medical practice, but that
a greater effect can be expected if resource availability is
also improved.
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